Tarsus Pharmaceuticals (TARS) Insider Trading & Ownership $52.36 +2.39 (+4.78%) Closing price 04:00 PM EasternExtended Trading$52.36 0.00 (0.00%) As of 05:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.25%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$1.28 M Get TARS Insider Trade Alerts Want to know when executives and insiders are buying or selling Tarsus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TARS Insider Buying and Selling by Quarter Remove Ads Tarsus Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/20/2025Bobak R AzamianCEOSell8,534$50.11$427,638.74 3/20/2025Bryan WahlGeneral CounselSell3,084$50.11$154,539.24 3/20/2025Dianne C WhitfieldInsiderSell2,137$50.11$107,085.07 3/18/2025Bobak R AzamianCEOSell7,131$46.29$330,093.99 3/18/2025Bryan WahlGeneral CounselSell3,341$46.29$154,654.89 3/18/2025Dianne C WhitfieldInsiderSell2,315$46.29$107,161.35 (Data available from 1/1/2013 forward) TARS Insider Trading Activity - Frequently Asked Questions Who is on Tarsus Pharmaceuticals's Insider Roster? The list of insiders at Tarsus Pharmaceuticals includes Andrew D Goldberg, Aziz Mottiwala, Bobak R Azamian, Bryan Wahl, Dianne C Whitfield, Elizabeth Yeu Lin, Jose M Trevejo, Leonard M Greenstein, Mark J Holdbrook, Michael Ackermann, Seshadri Neervannan, and Vivo Capital Ix, Llc. Learn more on insiders at TARS. What percentage of Tarsus Pharmaceuticals stock is owned by insiders? 8.25% of Tarsus Pharmaceuticals stock is owned by insiders. Learn more on TARS's insider holdings. Which Tarsus Pharmaceuticals insiders have been buying company stock? The following insiders have purchased TARS shares in the last 24 months: Andrew D Goldberg ($18,960.00), and Elizabeth Yeu Lin ($159,700.80). How much insider buying is happening at Tarsus Pharmaceuticals? Insiders have purchased a total of 10,506 TARS shares in the last 24 months for a total of $178,660.80 bought. Which Tarsus Pharmaceuticals insiders have been selling company stock? The following insiders have sold TARS shares in the last 24 months: Aziz Mottiwala ($235,840.83), Bobak R Azamian ($5,618,771.30), Bryan Wahl ($581,222.09), Dianne C Whitfield ($350,516.47), Jose M Trevejo ($73,912.00), Leonard M Greenstein ($70,100.00), and Seshadri Neervannan ($149,297.40). How much insider selling is happening at Tarsus Pharmaceuticals? Insiders have sold a total of 323,678 Tarsus Pharmaceuticals shares in the last 24 months for a total of $7,079,660.09 sold. Tarsus Pharmaceuticals Key ExecutivesDr. Bobak R. Azamian M.D.Co-Founder, President, CEO & ChairmanMr. Jeffrey S. Farrow (Age 62)CFO & Chief Strategy Officer Compensation: $722.95kDr. Seshadri Neervannan Ph.D. (Age 56)Chief Operating Officer Compensation: $759.2kDr. Elizabeth Yeu Lin M.D. (Age 46)Chief Medical Advisor & Director Compensation: $59.12kMr. David NakasoneHead of Investor RelationsDr. Bryan Wahl J.D. (Age 46)M.D., General Counsel & Corporate Secretary Compensation: $619.09kMs. Adrienne KempSenior Director of Corporate CommunicationsMr. Matthew Rossen M.B.A. (Age 46)Vice President of Marketing Mr. Scott YoumansVice President of SalesMs. Dianne C. Whitfield M.S.W. (Age 47)Chief Human Resources Officer Compensation: $578.9k2 recent trades More Insider Trading Tools from MarketBeat Related Companies Revolution Medicines Insider Trades Lantheus Insider Trades TG Therapeutics Insider Trades BridgeBio Pharma Insider Trades Axsome Therapeutics Insider Trades Blueprint Medicines Insider Trades Grifols Insider Trades Nuvalent Insider Trades Krystal Biotech Insider Trades Verona Pharma Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It MattersInsider Scoop: 4 Stocks Insiders Are Buying and Selling2 Stocks Insiders Are Buying and 1 They're Selling This page (NASDAQ:TARS) was last updated on 3/24/2025 by MarketBeat.com Staff From Our PartnersThis could put Trump on new $100 billAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredElon x DOGE = Government backed Smokescreen???While the mainstream media obsesses over Elon's new Department of Government Efficiency... A much BIGGER st...InvestorPlace | SponsoredElon Musk just flipped the script on AI Elon Musk’s Secret AI Project Could Spark the Next Stock Explosion Elon Musk just blindsided Nvidia, Micr...Behind the Markets | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tarsus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
